By Michael J. Joyner, Nigel Paneth and Arturo Casadevall he FDA’s withdrawal of its authorization for Evusheld, a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, bebtelovimab,...
Covid convalescent plasma: the ‘little engine that could’
read more